Spots Global Cancer Trial Database for The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study
Official Title: The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study
Study ID: NCT05804331
Interventions
Study Description
Brief Summary: To determine the long term outcomes of Endoscopic Submucosal Dissection (ESD), Endoscopic Full Thickness Resection (EFTR) and Submucosal-Tunnelling Endoscopic Resection (STER) for upper gastrointestinal neoplastic lesions
Detailed Description: To collect prospective observational data on patients undergoing ESD, EFTR or STER for UGI neoplastic lesions * Lesion characteristics including histology * Procedural outcomes * Safety Outcomes * Efficacy outcomes
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Westmead Hospital, Sydney, New South Wales, Australia
Contact Details
Name: Michael Bourke
Affiliation: WSLHD
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
